Americann EBITDA per Share
The EBITDA per Share of Americann (ACAN) as of Jul 22, 2026 is -0.03 USD. In the previous year, EBITDA per Share was 0.03 USD — a change of -221.89% (lower).
Get this data via API
Financial Data API
EBITDA per Share
-0.03USD
YoY
-221.89%
Last updated:
EBITDA per Share of Americann is 2026 -0.03 USD. EBITDA per Share of Americann was 2025 0.03 USD. It decreases by -221.89% lower compared to the previous year.
Access this data via the Eulerpool API
Americann Stock analysis
What does Americann do? Americann Inc is a US-based company that specializes in the legalization and cultivation of cannabis-based products. It was founded in 2010 by Tim Keogh, an experienced entrepreneur and investor. Americann's business model focuses on creating value through investments in various sectors of the cannabis industry. This includes companies involved in cultivation and production, technology and innovation, as well as sales and distribution. The company aims to achieve diversification in its investments to create long-term value for its investors. Americann does not offer its own products or services, but instead invests in companies within the cannabis industry. Americann is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Americann stock
EBITDA per Share of Americann is -0.03 USD in 2026.
Access this data via the Eulerpool API
Income Statement — Americann
All Key Metrics — Americann
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth